MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0053375
KGN Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹51.45 Cr
▲ 22% YoY
Net profit · FY 2025
₹65.5 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹3.48 Cr
EBITDA margin 6.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
26 yrs
Est. 2000
Employees · EPFO
39
Provident fund records
Directors on board
4
As per MCA filings
About KGN Pharmaceuticals Private Limited
Data last updated:
KGN Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2000PTC128154. Its GSTIN is 27AABCK4445M1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Kgn Pharamaceuticals Priate Limited. It is led by directors including Pradeep Govind Patil (Whole-Time Director) and Mohammed Usman Khursheed Anwar Ansari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 310 311 3rd Floor Heenashopping Arcade S V Road Jogeshwari (West), Mumbai, Maharashtra, India – 400102.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.45 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹65.5 Lakh (net margin 1.3%) and EBITDA of ₹3.48 Cr (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 28% over five years.
The company has about 39 employees on its provident fund (EPFO) records.
Court records list 28 cases involving the company, including 4 filed by the company and 24 filed against it; 2 cases are pending.
KGN Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0053375). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kgnpharma.in.
Company details
CIN U24239MH2000PTC128154
Registration Number 128154
Incorporation Date 08 August 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0053375
Key People
Pradeep Govind Patil Whole-Time Director Mohammed Usman Khursheed Anwar Ansari Director Mohammed Sufyaan Khursheed Anwar Ansari Director Recognitions & Rankings of KGN Pharmaceuticals
Contact details
KGN Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is kgnpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address310 311 3rd Floor Heenashopping Arcade S V Road Jogeshwari (West), Mumbai, Maharashtra, India – 400102
- IndustryPharma, Drug Formulation & Development
To see the full contact details of KGN Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
KGN Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of KGN Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of KGN Pharmaceuticals Private Limited, buy the company report.
Financials of KGN Pharmaceuticals Private Limited
FY 2024 filings availableKGN Pharmaceuticals Private Limited reported revenue of ₹51.45 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹51.45 Cr ▲ 22%
Net profit · FY 2025
₹65.5 Lakh margin 1.3%
EBITDA · FY 2025
₹3.48 Cr margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 19%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 19%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 22% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KGN Pharmaceuticals Private Limited, buy the company report.
Board of directors of KGN Pharmaceuticals Private Limited
KGN Pharmaceuticals has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Govind Patil Also directs: Karlson & Gibson Pharmaceuticals Private Limited | Whole-Time Director | 30 Sep 2015 | 11 Years 0 Months | Current |
| Mohammed Usman Khursheed Anwar Ansari Also directs: Karlson & Gibson Pharmaceuticals Private Limited | Director | 27 Feb 2018 | 8 Years 7 Months | Current |
| Mohammed Sufyaan Khursheed Anwar Ansari Also directs: Karlson & Gibson Pharmaceuticals Private Limited | Director | 01 Dec 2014 | 11 Years 10 Months | Current |
| Khursheed Anwar Mohammad Ali Ansari Also directs: Karlson & Gibson Pharmaceuticals Private Limited | Director | 12 Aug 2002 | 24 Years 2 Months | Current |
Peer comparison
KGN Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Junna Life Sciences Private Limited | ₹51.69 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Nutron Pharmaceuticals Private Limited | ₹51.48 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Zenlabs Ethica Limited | ₹51.47 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| CNX Healthcare Private Limited | ₹51.46 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| KGN Pharmaceuticals Private Limitedthis company | ₹51.45 Cr (FY 2025) | ₹65.5 Lakh | 1.3% | 22.0% | 39 | Mumbai, Maharashtra, India |
| Salvavidas Pharmaceutical Private Limited | ₹51.23 Cr (FY 2025) | 50.0% | Surat, Gujarat, India |
To see the full peer comparison of KGN Pharmaceuticals Private Limited, buy the company report.
Auditor
KGN Pharmaceuticals Private Limited is audited by APMH & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APMH & Associates LLP | FY 2024 | 102699W/W100142 |
Shareholding
The shareholding of KGN Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of KGN Pharmaceuticals Private Limited, buy the company report.
Legal cases
KGN Pharmaceuticals Private Limited has 28 court cases on record: 4 filed by KGN Pharmaceuticals, 24 filed against it. 2 cases are pending and 26 are disposed.
Total cases
28
Filed by the company
4
Filed against the company
24
Pending
2
Disposed
26
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 26 | 23 | 2 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Astamed Healthcare (I) Pvt.Ltd. | Disposed |
| Bombay High Court | Court case (NMCD) | Filed against the company | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of KGN Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
KGN Pharmaceuticals Private Limited has 55 MSME Form 1 returns on record between 2012 and 2023, listing 1,460 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Integrity Packaging LLP | |||
| an individual supplier | |||
| Fancy Pack |
To see the full MSME payment records of KGN Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
KGN Pharmaceuticals Private Limited has a workforce of 39 employees on its EPFO records as of Mar 18, 2025, across 1 active EPFO establishment.
Employee count
39
Active EPFO establishments
1
Employee growth
21.88%
GST
KGN Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCK4445M1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of KGN Pharmaceuticals Private Limited, buy the company report.
Recent activity
KGN Pharmaceuticals Private Limited has 9 board changes on record since 2002: 4 appointments and 5 cessations. The latest: Mohammed Usman Khursheed Anwar Ansari was appointed as Director on 27 Feb 2018.
AGM
Kgn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Kgn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Mohammed Usman Khursheed Anwar Ansari was appointed as Director.
Ceased
Mohammed Usman Khursheed Anwar Ansari ceased to be Additional Director.
Ceased
Mohammad Zubair Mohammad Ali Ansari ceased to be Director.
Ceased
Mohammed Sufyaan Khursheed Anwar Ansari ceased to be Additional Director.
Appointed
Pradeep Govind Patil was appointed as Whole-Time Director.
Ceased
Pradeep Govind Patil ceased to be Additional Director.
Appointed
Mohammed Sufyaan Khursheed Anwar Ansari was appointed as Director.
Ceased
Nayeemuddin Quazi Rakmuddin Usmani ceased to be Director.
Appointed
Khursheed Anwar Mohammad Ali Ansari was appointed as Director.
Incorporation
08 Aug 2000
Kgn Pharmaceuticals Private Limited was registered on 08 Aug 2000 with Roc Mumbai & aged 26 years 2 months as per MCA records.
Frequently asked questions
KGN Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2000 (26+ years old) and is registered under CIN U24239MH2000PTC128154.
KGN Pharmaceuticals has 4 current directors:
- Pradeep Govind Patil - Whole-Time Director
- Mohammed Usman Khursheed Anwar Ansari - Director
- Mohammed Sufyaan Khursheed Anwar Ansari - Director
- Khursheed Anwar Mohammad Ali Ansari - Director
The latest financial statements of KGN Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of KGN Pharmaceuticals is 27AABCK4445M1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of KGN Pharmaceuticals is U24239MH2000PTC128154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KGN Pharmaceuticals has 28 court cases on record: 4 filed by the company and 24 filed against it. 2 are pending. Most are in the high courts.
KGN Pharmaceuticals was incorporated on 08 August 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of KGN Pharmaceuticals by revenue are Junna Life Sciences Private Limited, Nutron Pharmaceuticals Private Limited, Zenlabs Ethica Limited, CNX Healthcare Private Limited, Salvavidas Pharmaceutical Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammed Usman Khursheed Anwar Ansari was appointed as Director on 27 Feb 2018. Mohammed Usman Khursheed Anwar Ansari ceased to be Additional Director on 27 Feb 2018. Mohammad Zubair Mohammad Ali Ansari ceased to be Director on 18 Jan 2018. KGN Pharmaceuticals has 9 board changes on record in total.
Yes, KGN Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0053375).
KGN Pharmaceuticals has 55 MSME Form 1 returns on record between 2012 and 2023, listing 1,460 overdue payments to 45 micro and small suppliers. The latest return was filed on 21 Nov 2023.
KGN Pharmaceuticals can be reached through the website kgnpharma.in. Its registered office is in Mumbai, Maharashtra, India.